胎儿肝脏输注用于一名患有白消安毒性的慢性髓性白血病患者。
Foetal liver infusion in a chronic myeloid leukemia patient with busulphan toxicity.
作者信息
Sharma S, Kochupillai V, Pati H P
机构信息
Department of Laboratory Medicine (Haematology), Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi.
出版信息
Med Oncol. 1998 Apr;15(1):70-1. doi: 10.1007/BF02787349.
PMID:9643535
Abstract
A 36-year-old man suffering from chronic myeloid leukemia (in chronic phase) was initially treated with busulphan. At the end of 6 months of follow-up he developed bone marrow aplasia. He was given single foetal liver infusion therapy. The patient recovered fully from aplasia. He continued in chronic phase for more than 7 years with intermittent busulphan therapy.
摘要
一名36岁患有慢性粒细胞白血病（慢性期）的男性最初接受白消安治疗。在随访6个月结束时，他出现了骨髓再生障碍。他接受了单次胎肝输注治疗。患者再生障碍完全康复。他通过间歇性白消安治疗在慢性期持续了7年多。
Zotero 插件